Dr. Simone Douglas-Green (@DrBlackBoots on Twitter/X and Instagram) is a new Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, where she has been named a BME Distinguished Faculty Fellow. She received her B.S. in Biomedical Engineering from the University of Miami, and her Ph.D. in Biomedical Engineering from the joint program at Georgia Tech and Emory University. Dr. Douglas-Green’s professional and scholarly development as a doctoral and postdoctoral trainee has been supported by a number of awards including the Alfred P. Sloan Foundation's Minority Ph.D. (MPHD) Fellowship, NASEM Ford Foundation Postdoctoral Fellowship, and Burroughs Wellcome Fund Postdoctoral Enrichment Program (PDEP). The Douglas-Green Lab focuses on developing tools/techniques to study how biology interacts with nanoparticles with an emphasis on understanding person and disease specific proteins coronas. Her goal is to train the next generation of engineers to be “EPIC”- engineering with purpose, intentionality, and compassion.

Dr. Leslie Chan is an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Tech School of Engineering and Emory School of Medicine. Her research program integrates core and emerging principles from drug delivery, biomaterials development, and chemical biology to engineer diagnostic and therapeutic solutions for infectious disease, microbiome dysbiosis, and inflammatory diseases. Dr. Chan earned her B.S. in Biomedical Engineering from Georgia Tech and her Ph.D. in Bioengineering from the University of Washington with Professor Suzie Pun. She completed her postdoctoral training at Massachusetts Institute of Technology with Professor Sangeeta Bhatia. Dr. Chan is the recipient of an NIH K99/R00 Pathway to Independence Award.

Yonggang Ke's research is highly interdisciplinary combining chemistry, biology, physics, material science, and engineering. The overall mission of his research is to use interdisciplinary research tools to program nucleic-acid-based "beautiful structures and smart devices" at nanoscale, and use them for scientific exploration and technological applications. Specifically, his team focuses on (1) developing new DNA self-assembly paradigms for constructing DNA nanostructures with greater structural complexity, and with controllable sizes and shapes; (2) developing new imaging or drug delivery systems based on DNA nanostructuresl; (3) exploring design of novel DNA-based nanodevices for understanding basic biological questions at molecular level; (4) developing DNA-templated protein devices for constructing artificial bio-reactors.

For cancer-related research/application, Ke will focus on using DNA/RNA nanostructures as drug delivery vehicles. He is also interested in using DNA/RNA nanostructures to study cancer cell biology at molecular level.